Ypsomed
Overview
Ypsomed is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 35 years of experience. The company is headquartered in Burgdorf, Switzerland, and has a global presence, developing, manufacturing, and marketing injection pens, autoinjectors, and infusion systems for pharmaceutical companies and patients. Ypsomed focuses on innovative solutions for subcutaneous drug delivery, aiming to improve the lives of people with diabetes and other chronic conditions.
About Us
Ypsomed, a leading diabetes specialist with over 35 years of experience, develops and manufactures injection and infusion systems for self-medication. With a global workforce exceeding 2000 employees, Ypsomed is headquartered in Burgdorf, Switzerland, and operates an extensive global manufacturing network. The company is recognized as a leader in self-injection solutions, offering pharmaceutical companies and patients comprehensive platforms and preferred partnership opportunities for pens, autoinjectors, and pump systems designed for administering liquid drugs. Ypsomed's expertise and comprehensive offerings position it as a preferred partner in the self-injection market.
Vision
To shape the future of self-medication with innovative and reliable solutions.
Mission
To be the preferred partner for self-injection and infusion systems, improving the lives of patients and enabling successful drug delivery.
Headquarters
New Delhi
Specialties & Industries
Open Positions
No open positions at the moment
Check back later for new opportunities